Skip to content
10-Q

Quarterly Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-22-003449

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · May 16, 2022 404.22M sh
Cash And Equivalents Q2 2022 · Mar 31, 2022 $3.05K
Cash And Equivalents Q2 2022 · Sep 30, 2021 $25.3K
Cash And Equivalents Q2 2022 · Mar 31, 2021 $13.52K
Cash And Equivalents Q2 2022 · Sep 30, 2020 $12.2K
Stockholders Equity Q2 2022 · Mar 31, 2022 −$2.4M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$1.58M
Stockholders Equity Q2 2022 · Sep 30, 2021 −$1.69M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$1.87M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$1.75M
Stockholders Equity restated Q2 2022 · Sep 30, 2020 −$2.93M
Current Liabilities Q2 2022 · Mar 31, 2022 $2.56M
Current Liabilities Q2 2022 · Sep 30, 2021 $2.03M
Total Liabilities Q2 2022 · Mar 31, 2022 $2.6M
Total Liabilities Q2 2022 · Sep 30, 2021 $2.07M
Total Assets Q2 2022 · Mar 31, 2022 $198.4K
Total Assets Q2 2022 · Sep 30, 2021 $373.08K
Net Income Q2 2022 · Mar 31, 2022 −$1.02M
Net Income Q2 2022 · Mar 31, 2021 −$3.14M
Net Income Q2 2022 · Mar 31, 2021 −$3.56M
Net Income Q2 2022 · Dec 31, 2020 −$417.11K
Operating Cash Flow Q2 2022 · Mar 31, 2021 −$105.54K
Sga Expense Q2 2022 · Mar 31, 2021 $19.25K
Sga Expense Q2 2022 · Mar 31, 2021 $43.66K
Operating Income Q2 2022 · Mar 31, 2021 −$136.95K
Operating Income Q2 2022 · Mar 31, 2021 −$238.57K